New Technique Helps Detect Prostate Cancers Not Identified by MRI

Magnetic resonance imaging (MRI) cannot identify prostate cancer. Therefore, scientists have developed a new test called contrast-enhanced subharmonic imaging (SHI) to detect prostate cancer.

Prostate cancers are usually not detected by Magnetic resonance imaging (MRI). However, a novel test called contrast-enhanced subharmonic imaging (SHI) can now help identify prostate cancer, reveals a new study.//

SHI is a new technique for imaging of microbubble ultrasound contrast agents with improved suppression of background tissues.

Brachytherapy for Prostate Cancer - Doses, Side Effects, Precautions
Learn about two different types of brachytherapy used for treating prostate cancer. Get information on the latest advances in the field.

‘Prostate cancer can be readily visible with the new technique called contrast-enhanced subharmonic imaging (SHI).’

The study was presented by Venkata Masarapu of Jefferson Medical College of Thomas Jefferson University at the ARRS 2018 Annual Meeting in Washington, DC.

The study was conducted to evaluate contrast enhanced SHI of the prostate for detection of prostate cancer.

Among the study group of 28 patients, contrast enhancement was clearly observed with color and power Doppler imaging, as well as with both harmonic imaging (HI) and SHI techniques in all subjects.

Decipher Test for Prostate Cancer - Indications, Procedure & Results
Decipher test a genomic test for prostate cancer that determines the aggressiveness of the cancer and helps in planning the treatment course for the cancer.

SHI provided improved contrast signal and tissue suppression relative to conventional HI.

Areas of increased vascularity were best delineated with maximum-intensity projection SHI, which allowed visualization of microvascular architecture.

Drugs for Prostate Cancer - Treatment, Side Effects & Precautions
Prostate cancer is the main cause of cancer death in men. One of the treatment method includes prescribing chemotherapeutic or hormonal drugs. These are prescribed depending on the type and stage of cancer.

This first in vivo application of contrast-enhanced SHI demonstrated contrast enhancement in the prostate of every study patient, with focal areas of contrast enhancement corresponding to sites of cancer in 18 percent of targeted biopsies, including five patients whose cancer was not identified by MRI.

The results indicate that SHI provides improved conspicuity of microbubble contrast enhancement and may improve the performance of contrast-enhanced ultrasound for detection of prostate cancer.

External Beam Radiation Therapy for Prostate Cancer
In depth information about various types of external beam radiotherapy for treatment of prostate cancer. Radiotherapy is an alternative to surgical treatment such as radical prostatectomy.

Source-Eurekalert